Development and internal validation of a risk score for subsidence of expandable spacers in transforaminal lumbar interbody fusion (TLIF) surgery

开发并内部验证经椎间孔腰椎椎体间融合术(TLIF)中可扩张垫片下沉风险评分

阅读:1

Abstract

INTRODUCTION: Subsidence of transforaminal lumbar interbody fusion (TLIF) cages is a common complication. Little is known about risk factors for cage subsidence (CS) of expandable spacers. RESEARCH QUESTION: To develop a score for CS risk stratification. MATERIAL AND METHODS: We reviewed consecutive patients treated by TLIF with a specific type of expandable interbody implant. CS at the 3-month follow-up was defined as primary endpoint. We identified risk factors, calculated their effect sizes using multivariable logistic regression models and developed the Expandable TLIF Subsidence Index (ETSI). Area Under the Receiver Operating Curve (AUROC) was performed. RESULTS: We identified n = 388 patients (mean age 64.8 years, 55.9 % female), in which we performed TLIF at 482 levels. CS at 3 months was evident in n = 123 patients and on 153 levels (31.7 %). Independent risk factors for CS were high ASA score (3&4; odds ratio (OR) 2.19, 95 % confidence interval (CI) 1.37-3.50, p = 0.008), indication for surgery other than degenerative or deformity (4.79, 1.75-13.1, p = 0.002), lower lumbar spine (L3/4-L5/S1; 4.31, 1.46-12.7, p = 0.008), small cage size (1.94, 1.22-3.07, p = 0.005), and more posterior position of the cage in the intervertebral space (1.68, 1.15-2.43, p = 0.007). The ETSI with a range from -2-6 points obtained an AUROC of 0.6807, indicating a moderate classification result. For each 1-step increase in the ETSI, an OR of 2.02 (1.63-2.50, p < 0.001) to develop CS was calculated and it predicted 3- and 12-month non-union risk. DISCUSSION AND CONCLUSIONS: We identified risk factors for CS, some of which have strong effect sizes and are potentially modifiable.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。